Zevra Therapeutics, Inc. (ZVRA)
12.54
+0.24
(+1.91%)
USD |
NASDAQ |
Sep 03, 16:00
12.54
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Net Income (Annual) : 77.58M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 77.58M |
| December 31, 2024 | -105.51M |
| December 31, 2023 | -46.05M |
| December 31, 2022 | -26.77M |
| December 31, 2021 | -8.555M |
| December 31, 2020 | -12.76M |
| December 31, 2019 | -24.52M |
| Date | Value |
|---|---|
| December 31, 2018 | -56.47M |
| December 31, 2017 | -43.39M |
| December 31, 2016 | -16.52M |
| December 31, 2015 | -54.66M |
| December 31, 2014 | -24.45M |
| December 31, 2013 | -5.226M |
| December 31, 2012 | -0.0704M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Innoviva, Inc. | 271.16M |
| Collegium Pharmaceutical, Inc. | 62.87M |
| Johnson & Johnson | 26.80B |
| Ligand Pharmaceuticals, Inc. | 124.45M |
| Harrow, Inc. | -5.139M |